Hedge Fund - Tang Capital Management
Heron Therapeutics Inc. (HRTX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $4,918,010 | 0.27% | 2,235,459 | $1.94 |
| 2 | 2024 - Q4 (2024-12-31) | $3,274,615 | 0.21% | 2,140,271 | $1.62 |
| 3 | 2024 - Q3 (2024-09-30) | $3,681,500 | 0.26% | 1,850,000 | $2.39 |
| 4 | 2024 - Q2 (2024-06-30) | $6,475,000 | 0.65% | 1,850,000 | $3.07 |
| 5 | 2024 - Q1 (2024-03-31) | $5,124,500 | 0.53% | 1,850,000 | $2.51 |
| 6 | 2023 - Q4 (2023-12-31) | $3,145,000 | 0.29% | 1,850,000 | $1.10 |
| 7 | 2023 - Q3 (2023-09-30) | $1,905,500 | 0.26% | 1,850,000 | $1.42 |
| 8 | 2023 - Q2 (2023-06-30) | $2,146,000 | 0.31% | 1,850,000 | $1.78 |
| 9 | 2023 - Q1 (2023-03-31) | $830,500 | 0.12% | 550,000 | $2.50 |
| 10 | 2022 - Q4 (2022-12-31) | $9,389,835 | 1.36% | 3,755,934 | $3.22 |
| 11 | 2022 - Q3 (2022-09-30) | $28,865,000 | 3.53% | 6,840,000 | $3.91 |
| 12 | 2022 - Q2 (2022-06-30) | $10,379,000 | 1.57% | 3,720,000 | $4.02 |
| 13 | 2022 - Q1 (2022-03-31) | $21,278,000 | 4.25% | 3,720,000 | $7.32 |
| 14 | 2021 - Q4 (2021-12-31) | $71,058,000 | 14.29% | 7,782,928 | $10.21 |
| 15 | 2021 - Q3 (2021-09-30) | $84,527,000 | 17.54% | 7,907,087 | $12.17 |
| 16 | 2021 - Q2 (2021-06-30) | $122,718,000 | 24.42% | 7,907,087 | $15.91 |
| 17 | 2020 - Q4 (2020-12-31) | $0 | 0% | 0 | $17.38 |
| 18 | 2020 - Q3 (2020-09-30) | $42,932,000 | 7.76% | 2,896,904 | $15.60 |
| 19 | 2020 - Q2 (2020-06-30) | $42,613,000 | 4.14% | 2,896,904 | $16.43 |
| 20 | 2020 - Q1 (2020-03-31) | $34,010,000 | 4.77% | 2,896,904 | $18.80 |
| 21 | 2019 - Q4 (2019-12-31) | $117,904,000 | 14.08% | 5,017,203 | $22.12 |
| 22 | 2019 - Q3 (2019-09-30) | $102,011,000 | 17.45% | 5,514,096 | $18.40 |
| 23 | 2019 - Q2 (2019-06-30) | $106,783,000 | 14.43% | 5,744,096 | $19.98 |
| 24 | 2019 - Q1 (2019-03-31) | $140,386,000 | 25.86% | 5,744,096 | $26.18 |
| 25 | 2018 - Q4 (2018-12-31) | $150,933,000 | 34.62% | 5,818,541 | $27.49 |
| 26 | 2018 - Q3 (2018-09-30) | $188,343,000 | 30.75% | 5,950,826 | $37.25 |
| 27 | 2018 - Q2 (2018-06-30) | $335,952,000 | 42.58% | 8,647,398 | $31.84 |
| 28 | 2018 - Q1 (2018-03-31) | $238,692,000 | 35.07% | 8,648,252 | $22.68 |
| 29 | 2017 - Q4 (2017-12-31) | $153,242,000 | 24.27% | 8,466,377 | $16.31 |
| 30 | 2017 - Q3 (2017-09-30) | $139,596,000 | 42.62% | 8,643,739 | $15.69 |
| 31 | 2017 - Q2 (2017-06-30) | $119,716,000 | 42.49% | 8,643,739 | $14.48 |
| 32 | 2017 - Q1 (2017-03-31) | $129,824,000 | 46.92% | 8,654,914 | $13.84 |
| 33 | 2016 - Q4 (2016-12-31) | $81,183,000 | 43.29% | 6,197,198 | $15.69 |
| 34 | 2016 - Q3 (2016-09-30) | $106,778,000 | 44.28% | 6,197,198 | $18.55 |
| 35 | 2016 - Q2 (2016-06-30) | $111,860,000 | 49.83% | 6,197,198 | $19.52 |
| 36 | 2016 - Q1 (2016-03-31) | $98,574,000 | 44.88% | 5,190,837 | $19.73 |
| 37 | 2015 - Q4 (2015-12-31) | $138,595,000 | 54.99% | 5,190,837 | $26.74 |
| 38 | 2015 - Q3 (2015-09-30) | $126,657,000 | 46.7% | 5,190,837 | $33.33 |
| 39 | 2015 - Q2 (2015-06-30) | $161,746,000 | 49.07% | 5,190,837 | $18.81 |
| 40 | 2015 - Q1 (2015-03-31) | $71,580,000 | 38.07% | 4,919,625 | $11.27 |
| 41 | 2014 - Q4 (2014-12-31) | $49,491,000 | 27.13% | 4,919,625 | $8.16 |
| 42 | 2014 - Q3 (2014-09-30) | $40,980,000 | 21.23% | 4,919,625 | $9.31 |
| 43 | 2014 - Q2 (2014-06-30) | $60,610,000 | 28.06% | 4,919,625 | $11.95 |
| 44 | 2014 - Q1 (2014-03-31) | $61,329,000 | 29.74% | 4,408,987 | $12.60 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:20.0000 on 2014-01-13